

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 9.20232911 |
| 2 | central nervous system myelination (GO:0022010) | 9.20232911 |
| 3 | fatty acid elongation (GO:0030497) | 6.10251496 |
| 4 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.76876079 |
| 5 | postsynaptic membrane organization (GO:0001941) | 5.75546454 |
| 6 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.38088809 |
| 7 | myelination (GO:0042552) | 5.08778739 |
| 8 | axon ensheathment (GO:0008366) | 5.06665790 |
| 9 | ensheathment of neurons (GO:0007272) | 5.06665790 |
| 10 | nucleobase catabolic process (GO:0046113) | 4.67120725 |
| 11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.57275816 |
| 12 | negative regulation of neurotransmitter transport (GO:0051589) | 4.50070068 |
| 13 | presynaptic membrane organization (GO:0097090) | 4.47476433 |
| 14 | neurotransmitter secretion (GO:0007269) | 4.32940117 |
| 15 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.27628534 |
| 16 | neuron cell-cell adhesion (GO:0007158) | 4.27169226 |
| 17 | regulation of synaptic vesicle transport (GO:1902803) | 4.22389275 |
| 18 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.17741723 |
| 19 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.15322785 |
| 20 | presynaptic membrane assembly (GO:0097105) | 4.15266570 |
| 21 | regulation of synapse structural plasticity (GO:0051823) | 4.11308975 |
| 22 | negative regulation of protein localization to cell surface (GO:2000009) | 3.87119967 |
| 23 | cell migration in hindbrain (GO:0021535) | 3.87080513 |
| 24 | cholesterol biosynthetic process (GO:0006695) | 3.83967666 |
| 25 | regulation of collateral sprouting (GO:0048670) | 3.83856834 |
| 26 | myelin maintenance (GO:0043217) | 3.82162595 |
| 27 | locomotory exploration behavior (GO:0035641) | 3.81300113 |
| 28 | neuronal action potential propagation (GO:0019227) | 3.78615183 |
| 29 | auditory behavior (GO:0031223) | 3.78084783 |
| 30 | exploration behavior (GO:0035640) | 3.74025219 |
| 31 | cellular potassium ion homeostasis (GO:0030007) | 3.73915400 |
| 32 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.64840480 |
| 33 | apical protein localization (GO:0045176) | 3.64814763 |
| 34 | response to methylmercury (GO:0051597) | 3.60177320 |
| 35 | layer formation in cerebral cortex (GO:0021819) | 3.59412703 |
| 36 | oligodendrocyte differentiation (GO:0048709) | 3.58172393 |
| 37 | L-amino acid import (GO:0043092) | 3.50746505 |
| 38 | glycerophospholipid catabolic process (GO:0046475) | 3.48578476 |
| 39 | synapse assembly (GO:0007416) | 3.47186670 |
| 40 | neurotransmitter transport (GO:0006836) | 3.46001231 |
| 41 | sodium ion export (GO:0071436) | 3.44370923 |
| 42 | sterol biosynthetic process (GO:0016126) | 3.43498131 |
| 43 | glycosphingolipid biosynthetic process (GO:0006688) | 3.42872060 |
| 44 | synaptic vesicle endocytosis (GO:0048488) | 3.41914451 |
| 45 | adult walking behavior (GO:0007628) | 3.41477060 |
| 46 | regulation of neurotransmitter levels (GO:0001505) | 3.39217561 |
| 47 | synaptic vesicle exocytosis (GO:0016079) | 3.39198625 |
| 48 | response to auditory stimulus (GO:0010996) | 3.38234068 |
| 49 | substantia nigra development (GO:0021762) | 3.34728357 |
| 50 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.34658597 |
| 51 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.28222772 |
| 52 | neuron recognition (GO:0008038) | 3.27568370 |
| 53 | transmission of nerve impulse (GO:0019226) | 3.25038031 |
| 54 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.24532357 |
| 55 | asymmetric protein localization (GO:0008105) | 3.23696093 |
| 56 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.22179413 |
| 57 | eye photoreceptor cell differentiation (GO:0001754) | 3.18903428 |
| 58 | photoreceptor cell differentiation (GO:0046530) | 3.18903428 |
| 59 | positive regulation of synapse maturation (GO:0090129) | 3.16727691 |
| 60 | synaptic vesicle maturation (GO:0016188) | 3.15926525 |
| 61 | regulation of neurotransmitter secretion (GO:0046928) | 3.14661332 |
| 62 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.12818868 |
| 63 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.12501772 |
| 64 | acidic amino acid transport (GO:0015800) | 3.12347945 |
| 65 | astrocyte development (GO:0014002) | 3.11974155 |
| 66 | positive regulation of membrane potential (GO:0045838) | 3.11544957 |
| 67 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.11540181 |
| 68 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.11332555 |
| 69 | regulation of respiratory system process (GO:0044065) | 3.11004664 |
| 70 | negative regulation of axonogenesis (GO:0050771) | 3.09861353 |
| 71 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.07872268 |
| 72 | protein localization to synapse (GO:0035418) | 3.07100972 |
| 73 | neurotransmitter uptake (GO:0001504) | 3.07075894 |
| 74 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.06832305 |
| 75 | regulation of vesicle fusion (GO:0031338) | 3.06612522 |
| 76 | isoprenoid biosynthetic process (GO:0008299) | 3.06440867 |
| 77 | neuromuscular synaptic transmission (GO:0007274) | 3.05752476 |
| 78 | regulation of neurotransmitter transport (GO:0051588) | 3.02867763 |
| 79 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.02446234 |
| 80 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.02446234 |
| 81 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.02298942 |
| 82 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.01820300 |
| 83 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.00253556 |
| 84 | synapse organization (GO:0050808) | 2.98570676 |
| 85 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.98330796 |
| 86 | cerebellar granule cell differentiation (GO:0021707) | 2.97036992 |
| 87 | startle response (GO:0001964) | 2.95382990 |
| 88 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.94179755 |
| 89 | protein neddylation (GO:0045116) | 2.93343372 |
| 90 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.91907347 |
| 91 | C4-dicarboxylate transport (GO:0015740) | 2.90743710 |
| 92 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.90290762 |
| 93 | vocalization behavior (GO:0071625) | 2.90234487 |
| 94 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.89685276 |
| 95 | establishment of synaptic vesicle localization (GO:0097480) | 2.88618759 |
| 96 | synaptic vesicle transport (GO:0048489) | 2.88618759 |
| 97 | dendritic spine morphogenesis (GO:0060997) | 2.88531145 |
| 98 | potassium ion homeostasis (GO:0055075) | 2.88323341 |
| 99 | positive regulation of dendritic spine development (GO:0060999) | 2.87165245 |
| 100 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.86796244 |
| 101 | glutamate secretion (GO:0014047) | 2.86720182 |
| 102 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.86217434 |
| 103 | regulation of postsynaptic membrane potential (GO:0060078) | 2.85808962 |
| 104 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.85745972 |
| 105 | axonal fasciculation (GO:0007413) | 2.85517060 |
| 106 | response to redox state (GO:0051775) | 2.84171907 |
| 107 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.83257126 |
| 108 | creatine metabolic process (GO:0006600) | 2.82828740 |
| 109 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.82637500 |
| 110 | neuron-neuron synaptic transmission (GO:0007270) | 2.81790966 |
| 111 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.81457244 |
| 112 | neuron remodeling (GO:0016322) | 2.81232085 |
| 113 | dendritic spine organization (GO:0097061) | 2.80784495 |
| 114 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.80403556 |
| 115 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.80260534 |
| 116 | neuronal ion channel clustering (GO:0045161) | 2.79417536 |
| 117 | glutamate receptor signaling pathway (GO:0007215) | 2.78792629 |
| 118 | axon development (GO:0061564) | 2.78672490 |
| 119 | synaptic transmission, glutamatergic (GO:0035249) | 2.78086239 |
| 120 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.78061561 |
| 121 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.77970793 |
| 122 | regulation of synapse assembly (GO:0051963) | 2.77431131 |
| 123 | limb bud formation (GO:0060174) | 2.75104503 |
| 124 | gamma-aminobutyric acid transport (GO:0015812) | 2.75041951 |
| 125 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.74670116 |
| 126 | amino acid import (GO:0043090) | 2.74220299 |
| 127 | synaptic transmission (GO:0007268) | 2.73914158 |
| 128 | nerve growth factor signaling pathway (GO:0038180) | 2.68565961 |
| 129 | * establishment of mitochondrion localization (GO:0051654) | 2.67346466 |
| 130 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.67346466 |
| 131 | mitochondrion transport along microtubule (GO:0047497) | 2.67346466 |
| 132 | protein palmitoylation (GO:0018345) | 2.66198762 |
| 133 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.65846668 |
| 134 | regulation of dopamine metabolic process (GO:0042053) | 2.64224906 |
| 135 | regulation of catecholamine metabolic process (GO:0042069) | 2.64224906 |
| 136 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.63327592 |
| 137 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.61814637 |
| 138 | positive regulation of synapse assembly (GO:0051965) | 2.61094984 |
| 139 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.60626891 |
| 140 | dendrite morphogenesis (GO:0048813) | 2.59853816 |
| 141 | membrane tubulation (GO:0097320) | 2.58855578 |
| 142 | negative regulation of axon extension (GO:0030517) | 2.58725231 |
| 143 | amyloid precursor protein metabolic process (GO:0042982) | 2.58056441 |
| 144 | myelination in peripheral nervous system (GO:0022011) | 2.57502325 |
| 145 | peripheral nervous system axon ensheathment (GO:0032292) | 2.57502325 |
| 146 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.56202343 |
| 147 | glycine transport (GO:0015816) | 2.56017605 |
| 148 | chaperone-mediated protein transport (GO:0072321) | 2.54900066 |
| 149 | negative regulation of synaptic transmission (GO:0050805) | 2.54873577 |
| 150 | adult locomotory behavior (GO:0008344) | 2.54273406 |
| 151 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.54229177 |
| 152 | peptidyl-cysteine modification (GO:0018198) | 2.52792681 |
| 153 | detection of temperature stimulus (GO:0016048) | 2.52588346 |
| 154 | positive regulation of action potential (GO:0045760) | 2.51633826 |
| 155 | regulation of lipoprotein metabolic process (GO:0050746) | 2.51274056 |
| 156 | mechanosensory behavior (GO:0007638) | 2.50777856 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.19551090 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.82528589 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.86889019 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.76302565 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.72828800 |
| 6 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.46508783 |
| 7 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.40680213 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.38749825 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.38749825 |
| 10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.34796020 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.31546149 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.30107575 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.29743344 |
| 14 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.26330467 |
| 15 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.25807173 |
| 16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.24291249 |
| 17 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.23943213 |
| 18 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.10324974 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.08653110 |
| 20 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.06712378 |
| 21 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.99862597 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.95402038 |
| 23 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.95168267 |
| 24 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.92822027 |
| 25 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.89642795 |
| 26 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.75735312 |
| 27 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.75654323 |
| 28 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.75087788 |
| 29 | VDR_22108803_ChIP-Seq_LS180_Human | 1.73250160 |
| 30 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.69323059 |
| 31 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.67932088 |
| 32 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.65951466 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.65499164 |
| 34 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.65371427 |
| 35 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.62000002 |
| 36 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.61157627 |
| 37 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.60012206 |
| 38 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.57091417 |
| 39 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.55382199 |
| 40 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.55001877 |
| 41 | P300_19829295_ChIP-Seq_ESCs_Human | 1.53842656 |
| 42 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.52382522 |
| 43 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.52089085 |
| 44 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.49020382 |
| 45 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.49002437 |
| 46 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.48225186 |
| 47 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.45887850 |
| 48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.43702621 |
| 49 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.36955145 |
| 50 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.36414633 |
| 51 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.35496826 |
| 52 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.34795016 |
| 53 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.32858400 |
| 54 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32447310 |
| 55 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.31845805 |
| 56 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.28388189 |
| 57 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.27042974 |
| 58 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.26689764 |
| 59 | FUS_26573619_Chip-Seq_HEK293_Human | 1.25722320 |
| 60 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.25162731 |
| 61 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.23355804 |
| 62 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.22417892 |
| 63 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.20391637 |
| 64 | STAT3_23295773_ChIP-Seq_U87_Human | 1.18574718 |
| 65 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.16363908 |
| 66 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.16326326 |
| 67 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.14561571 |
| 68 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.14350661 |
| 69 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.12589787 |
| 70 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.12221822 |
| 71 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.08848480 |
| 72 | AR_19668381_ChIP-Seq_PC3_Human | 1.08336948 |
| 73 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.08087159 |
| 74 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.07905531 |
| 75 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07095138 |
| 76 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07086670 |
| 77 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.06926642 |
| 78 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06729775 |
| 79 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.05739908 |
| 80 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.05466220 |
| 81 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.05194923 |
| 82 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04728572 |
| 83 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.04688598 |
| 84 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.04629770 |
| 85 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.04552721 |
| 86 | TCF4_23295773_ChIP-Seq_U87_Human | 1.04126528 |
| 87 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.01880460 |
| 88 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.00622240 |
| 89 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.99058349 |
| 90 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.98389091 |
| 91 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97400299 |
| 92 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.97063483 |
| 93 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.96814126 |
| 94 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.96740206 |
| 95 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96349995 |
| 96 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.96253010 |
| 97 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.95903408 |
| 98 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95564332 |
| 99 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.94480255 |
| 100 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.93974914 |
| 101 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.93844157 |
| 102 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.93081849 |
| 103 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93055498 |
| 104 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.92403099 |
| 105 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.91582235 |
| 106 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.91582235 |
| 107 | JUN_21703547_ChIP-Seq_K562_Human | 0.91549801 |
| 108 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.91221944 |
| 109 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.90983857 |
| 110 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.90326222 |
| 111 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.90289523 |
| 112 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.89979720 |
| 113 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.89346482 |
| 114 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.89159829 |
| 115 | KDM2B_26808549_Chip-Seq_REH_Human | 0.88977644 |
| 116 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.88637946 |
| 117 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.87657657 |
| 118 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.86589452 |
| 119 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.86106194 |
| 120 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.86106194 |
| 121 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.85628951 |
| 122 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85469110 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.73394739 |
| 2 | MP0004270_analgesia | 3.74812962 |
| 3 | MP0000920_abnormal_myelination | 3.74624854 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 3.74398892 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 2.85939103 |
| 6 | MP0002272_abnormal_nervous_system | 2.82558827 |
| 7 | MP0002064_seizures | 2.78030450 |
| 8 | MP0001529_abnormal_vocalization | 2.76075688 |
| 9 | MP0001486_abnormal_startle_reflex | 2.63776688 |
| 10 | MP0005423_abnormal_somatic_nervous | 2.59154149 |
| 11 | MP0003329_amyloid_beta_deposits | 2.56628238 |
| 12 | MP0009745_abnormal_behavioral_response | 2.55671462 |
| 13 | MP0009046_muscle_twitch | 2.50157133 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.48685480 |
| 15 | MP0001968_abnormal_touch/_nociception | 2.47861328 |
| 16 | MP0000778_abnormal_nervous_system | 2.41233164 |
| 17 | * MP0002063_abnormal_learning/memory/cond | 2.26823524 |
| 18 | MP0002736_abnormal_nociception_after | 2.24579437 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.20690146 |
| 20 | MP0004142_abnormal_muscle_tone | 2.19654883 |
| 21 | MP0002572_abnormal_emotion/affect_behav | 2.18724820 |
| 22 | MP0004885_abnormal_endolymph | 2.13633229 |
| 23 | MP0004742_abnormal_vestibular_system | 2.10716671 |
| 24 | MP0003690_abnormal_glial_cell | 2.10083244 |
| 25 | MP0003950_abnormal_plasma_membrane | 2.07160230 |
| 26 | MP0005171_absent_coat_pigmentation | 1.96692366 |
| 27 | MP0001970_abnormal_pain_threshold | 1.94414340 |
| 28 | MP0003634_abnormal_glial_cell | 1.93306894 |
| 29 | MP0001440_abnormal_grooming_behavior | 1.88199171 |
| 30 | MP0002733_abnormal_thermal_nociception | 1.86350164 |
| 31 | MP0003136_yellow_coat_color | 1.84693152 |
| 32 | * MP0001905_abnormal_dopamine_level | 1.82430138 |
| 33 | MP0002067_abnormal_sensory_capabilities | 1.78498763 |
| 34 | MP0000955_abnormal_spinal_cord | 1.69385716 |
| 35 | MP0005394_taste/olfaction_phenotype | 1.61996486 |
| 36 | MP0005499_abnormal_olfactory_system | 1.61996486 |
| 37 | MP0002229_neurodegeneration | 1.59730436 |
| 38 | MP0006276_abnormal_autonomic_nervous | 1.57694541 |
| 39 | MP0008569_lethality_at_weaning | 1.57247888 |
| 40 | MP0002882_abnormal_neuron_morphology | 1.57191600 |
| 41 | MP0001485_abnormal_pinna_reflex | 1.56684231 |
| 42 | MP0005386_behavior/neurological_phenoty | 1.50417031 |
| 43 | MP0004924_abnormal_behavior | 1.50417031 |
| 44 | MP0005409_darkened_coat_color | 1.47805596 |
| 45 | MP0002184_abnormal_innervation | 1.47225782 |
| 46 | MP0003632_abnormal_nervous_system | 1.46371458 |
| 47 | * MP0002066_abnormal_motor_capabilities/c | 1.42655336 |
| 48 | MP0003631_nervous_system_phenotype | 1.41320396 |
| 49 | MP0005410_abnormal_fertilization | 1.38449957 |
| 50 | MP0003633_abnormal_nervous_system | 1.36845923 |
| 51 | MP0003121_genomic_imprinting | 1.36673666 |
| 52 | MP0002822_catalepsy | 1.36454992 |
| 53 | MP0002638_abnormal_pupillary_reflex | 1.32919108 |
| 54 | MP0001501_abnormal_sleep_pattern | 1.31451017 |
| 55 | MP0002557_abnormal_social/conspecific_i | 1.29990492 |
| 56 | MP0005646_abnormal_pituitary_gland | 1.28276090 |
| 57 | MP0005551_abnormal_eye_electrophysiolog | 1.28065046 |
| 58 | MP0002653_abnormal_ependyma_morphology | 1.26053173 |
| 59 | MP0000604_amyloidosis | 1.22869291 |
| 60 | MP0004043_abnormal_pH_regulation | 1.21977580 |
| 61 | MP0004811_abnormal_neuron_physiology | 1.20240825 |
| 62 | MP0001963_abnormal_hearing_physiology | 1.18511117 |
| 63 | MP0002752_abnormal_somatic_nervous | 1.16824365 |
| 64 | MP0006292_abnormal_olfactory_placode | 1.16402081 |
| 65 | MP0008789_abnormal_olfactory_epithelium | 1.16356207 |
| 66 | MP0008260_abnormal_autophagy | 1.16046359 |
| 67 | MP0004858_abnormal_nervous_system | 1.12273060 |
| 68 | MP0005645_abnormal_hypothalamus_physiol | 1.11011467 |
| 69 | MP0002102_abnormal_ear_morphology | 1.10743066 |
| 70 | MP0002152_abnormal_brain_morphology | 1.07512671 |
| 71 | MP0001984_abnormal_olfaction | 1.05137755 |
| 72 | MP0004134_abnormal_chest_morphology | 1.05079049 |
| 73 | MP0001986_abnormal_taste_sensitivity | 1.03109820 |
| 74 | MP0000049_abnormal_middle_ear | 1.01978325 |
| 75 | MP0008877_abnormal_DNA_methylation | 1.01427210 |
| 76 | MP0001299_abnormal_eye_distance/ | 1.00697345 |
| 77 | MP0002909_abnormal_adrenal_gland | 1.00259929 |
| 78 | MP0001502_abnormal_circadian_rhythm | 0.98187354 |
| 79 | MP0000462_abnormal_digestive_system | 0.94731509 |
| 80 | MP0004133_heterotaxia | 0.93907550 |
| 81 | MP0001177_atelectasis | 0.85464333 |
| 82 | MP0002234_abnormal_pharynx_morphology | 0.85323266 |
| 83 | MP0004145_abnormal_muscle_electrophysio | 0.84795996 |
| 84 | MP0009780_abnormal_chondrocyte_physiolo | 0.84079052 |
| 85 | MP0000026_abnormal_inner_ear | 0.83544459 |
| 86 | MP0003938_abnormal_ear_development | 0.82418040 |
| 87 | MP0000631_abnormal_neuroendocrine_gland | 0.82134646 |
| 88 | MP0005623_abnormal_meninges_morphology | 0.81502497 |
| 89 | MP0005167_abnormal_blood-brain_barrier | 0.80275096 |
| 90 | MP0001188_hyperpigmentation | 0.80268338 |
| 91 | MP0000747_muscle_weakness | 0.80019345 |
| 92 | MP0000579_abnormal_nail_morphology | 0.78014034 |
| 93 | MP0005195_abnormal_posterior_eye | 0.76623928 |
| 94 | MP0003119_abnormal_digestive_system | 0.75275353 |
| 95 | MP0005187_abnormal_penis_morphology | 0.75274124 |
| 96 | MP0003122_maternal_imprinting | 0.74557426 |
| 97 | MP0000751_myopathy | 0.69166157 |
| 98 | MP0010678_abnormal_skin_adnexa | 0.68767143 |
| 99 | MP0005253_abnormal_eye_physiology | 0.68239842 |
| 100 | MP0000569_abnormal_digit_pigmentation | 0.67290008 |
| 101 | MP0003137_abnormal_impulse_conducting | 0.66125779 |
| 102 | MP0002069_abnormal_eating/drinking_beha | 0.65921550 |
| 103 | MP0006072_abnormal_retinal_apoptosis | 0.65878133 |
| 104 | MP0001664_abnormal_digestion | 0.64047281 |
| 105 | MP0003861_abnormal_nervous_system | 0.63144420 |
| 106 | MP0004381_abnormal_hair_follicle | 0.62694708 |
| 107 | MP0001943_abnormal_respiration | 0.62415261 |
| 108 | MP0005248_abnormal_Harderian_gland | 0.61788502 |
| 109 | MP0001346_abnormal_lacrimal_gland | 0.61781943 |
| 110 | MP0000566_synostosis | 0.60559729 |
| 111 | MP0002233_abnormal_nose_morphology | 0.60101604 |
| 112 | MP0004085_abnormal_heartbeat | 0.59891507 |
| 113 | MP0002751_abnormal_autonomic_nervous | 0.57840630 |
| 114 | MP0002082_postnatal_lethality | 0.57554389 |
| 115 | MP0010770_preweaning_lethality | 0.57554389 |
| 116 | MP0010769_abnormal_survival | 0.57397982 |
| 117 | MP0004147_increased_porphyrin_level | 0.56875730 |
| 118 | MP0002090_abnormal_vision | 0.54836004 |
| 119 | MP0003787_abnormal_imprinting | 0.54319762 |
| 120 | MP0000647_abnormal_sebaceous_gland | 0.51803515 |
| 121 | MP0003879_abnormal_hair_cell | 0.51288748 |
| 122 | MP0008874_decreased_physiological_sensi | 0.51271231 |
| 123 | MP0004036_abnormal_muscle_relaxation | 0.50737041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.67739758 |
| 2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.67739758 |
| 3 | Neurofibrillary tangles (HP:0002185) | 5.47983688 |
| 4 | Abnormality of the corticospinal tract (HP:0002492) | 4.70554688 |
| 5 | Myokymia (HP:0002411) | 4.68695238 |
| 6 | Cerebral inclusion bodies (HP:0100314) | 4.15641174 |
| 7 | Focal motor seizures (HP:0011153) | 4.00435649 |
| 8 | Supranuclear gaze palsy (HP:0000605) | 3.94744183 |
| 9 | Termporal pattern (HP:0011008) | 3.84198882 |
| 10 | Insidious onset (HP:0003587) | 3.84198882 |
| 11 | Peripheral hypomyelination (HP:0007182) | 3.83242189 |
| 12 | Sensory axonal neuropathy (HP:0003390) | 3.60774660 |
| 13 | Polyphagia (HP:0002591) | 3.60436798 |
| 14 | Spastic gait (HP:0002064) | 3.53948311 |
| 15 | Ankle clonus (HP:0011448) | 3.40769620 |
| 16 | Parakeratosis (HP:0001036) | 3.31954995 |
| 17 | Increased serum pyruvate (HP:0003542) | 3.30498020 |
| 18 | Abnormality of glycolysis (HP:0004366) | 3.30498020 |
| 19 | Drooling (HP:0002307) | 3.25662662 |
| 20 | Pheochromocytoma (HP:0002666) | 3.23256280 |
| 21 | Onion bulb formation (HP:0003383) | 3.22570603 |
| 22 | Cerebral hypomyelination (HP:0006808) | 3.22422512 |
| 23 | Dysmetria (HP:0001310) | 3.19114537 |
| 24 | Epileptic encephalopathy (HP:0200134) | 3.09305749 |
| 25 | Scanning speech (HP:0002168) | 2.99255633 |
| 26 | Excessive salivation (HP:0003781) | 2.97131538 |
| 27 | Retinal dysplasia (HP:0007973) | 2.92435245 |
| 28 | Focal seizures (HP:0007359) | 2.88963348 |
| 29 | Leukodystrophy (HP:0002415) | 2.87606731 |
| 30 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.83688398 |
| 31 | Neuroendocrine neoplasm (HP:0100634) | 2.83061915 |
| 32 | Atonic seizures (HP:0010819) | 2.82345177 |
| 33 | Intention tremor (HP:0002080) | 2.81485532 |
| 34 | Action tremor (HP:0002345) | 2.79034458 |
| 35 | Epileptiform EEG discharges (HP:0011182) | 2.74448759 |
| 36 | Abnormality of the labia minora (HP:0012880) | 2.74321708 |
| 37 | Abnormal auditory evoked potentials (HP:0006958) | 2.69869354 |
| 38 | Hypsarrhythmia (HP:0002521) | 2.62235079 |
| 39 | EEG with generalized epileptiform discharges (HP:0011198) | 2.61302542 |
| 40 | Alacrima (HP:0000522) | 2.56358759 |
| 41 | Amyotrophic lateral sclerosis (HP:0007354) | 2.52748969 |
| 42 | Absent speech (HP:0001344) | 2.50858352 |
| 43 | Abnormality of the lower motor neuron (HP:0002366) | 2.49163985 |
| 44 | Lower limb muscle weakness (HP:0007340) | 2.47847637 |
| 45 | Abnormality of binocular vision (HP:0011514) | 2.47638859 |
| 46 | Diplopia (HP:0000651) | 2.47638859 |
| 47 | Akinesia (HP:0002304) | 2.46945481 |
| 48 | Mutism (HP:0002300) | 2.45571972 |
| 49 | Amblyopia (HP:0000646) | 2.44857059 |
| 50 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.44367668 |
| 51 | Spastic tetraplegia (HP:0002510) | 2.42509578 |
| 52 | Megalencephaly (HP:0001355) | 2.42232709 |
| 53 | Cortical dysplasia (HP:0002539) | 2.41884444 |
| 54 | Hyperventilation (HP:0002883) | 2.40172511 |
| 55 | Sleep apnea (HP:0010535) | 2.40108022 |
| 56 | Lissencephaly (HP:0001339) | 2.39923121 |
| 57 | Progressive cerebellar ataxia (HP:0002073) | 2.39099591 |
| 58 | Limb dystonia (HP:0002451) | 2.38795084 |
| 59 | Urinary urgency (HP:0000012) | 2.37114878 |
| 60 | Thickened helices (HP:0000391) | 2.37099609 |
| 61 | Failure to thrive in infancy (HP:0001531) | 2.36544099 |
| 62 | Broad-based gait (HP:0002136) | 2.33616449 |
| 63 | Congenital primary aphakia (HP:0007707) | 2.32840181 |
| 64 | Acute necrotizing encephalopathy (HP:0006965) | 2.30607711 |
| 65 | Nephrogenic diabetes insipidus (HP:0009806) | 2.30546100 |
| 66 | Hemiplegia (HP:0002301) | 2.28700714 |
| 67 | Split foot (HP:0001839) | 2.26254435 |
| 68 | Slow saccadic eye movements (HP:0000514) | 2.24602854 |
| 69 | Absent septum pellucidum (HP:0001331) | 2.20441541 |
| 70 | Hypoplasia of the corpus callosum (HP:0002079) | 2.19388058 |
| 71 | Anteriorly placed anus (HP:0001545) | 2.18273131 |
| 72 | Hypoplastic pelvis (HP:0008839) | 2.16651199 |
| 73 | Autoamputation (HP:0001218) | 2.15619740 |
| 74 | Vaginal atresia (HP:0000148) | 2.15255488 |
| 75 | Cerebral hemorrhage (HP:0001342) | 2.14912959 |
| 76 | Dialeptic seizures (HP:0011146) | 2.13823074 |
| 77 | CNS hypomyelination (HP:0003429) | 2.13081585 |
| 78 | Pachygyria (HP:0001302) | 2.12014679 |
| 79 | Hypoplasia of the brainstem (HP:0002365) | 2.11206288 |
| 80 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.11206288 |
| 81 | Torticollis (HP:0000473) | 2.09922944 |
| 82 | Genital tract atresia (HP:0001827) | 2.08977849 |
| 83 | Clumsiness (HP:0002312) | 2.08487729 |
| 84 | Progressive inability to walk (HP:0002505) | 2.05921500 |
| 85 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.05790009 |
| 86 | Aplasia of the phalanges of the hand (HP:0009802) | 2.05790009 |
| 87 | Aplasia involving bones of the extremities (HP:0009825) | 2.05790009 |
| 88 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.05424638 |
| 89 | Gait imbalance (HP:0002141) | 2.03625177 |
| 90 | Truncal ataxia (HP:0002078) | 2.00760490 |
| 91 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.99535968 |
| 92 | Status epilepticus (HP:0002133) | 1.99260597 |
| 93 | Foot dorsiflexor weakness (HP:0009027) | 1.99162157 |
| 94 | Poor speech (HP:0002465) | 1.98638532 |
| 95 | Decreased lacrimation (HP:0000633) | 1.98562330 |
| 96 | Poor suck (HP:0002033) | 1.98426554 |
| 97 | Dysdiadochokinesis (HP:0002075) | 1.97261017 |
| 98 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.97041439 |
| 99 | Decreased motor nerve conduction velocity (HP:0003431) | 1.95933898 |
| 100 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.95541558 |
| 101 | Abnormal eating behavior (HP:0100738) | 1.95210197 |
| 102 | Progressive macrocephaly (HP:0004481) | 1.94754009 |
| 103 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.93348661 |
| 104 | Hammertoe (HP:0001765) | 1.92333226 |
| 105 | Delusions (HP:0000746) | 1.92222524 |
| 106 | Neuronal loss in central nervous system (HP:0002529) | 1.91230453 |
| 107 | Absence seizures (HP:0002121) | 1.91052329 |
| 108 | Clonus (HP:0002169) | 1.90743703 |
| 109 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.90606468 |
| 110 | Postural instability (HP:0002172) | 1.90181168 |
| 111 | Increased circulating renin level (HP:0000848) | 1.88521456 |
| 112 | Genetic anticipation (HP:0003743) | 1.87895826 |
| 113 | Anxiety (HP:0000739) | 1.86589415 |
| 114 | Gaze-evoked nystagmus (HP:0000640) | 1.86429431 |
| 115 | Oligodactyly (hands) (HP:0001180) | 1.85710221 |
| 116 | Abnormality of the septum pellucidum (HP:0007375) | 1.85569781 |
| 117 | Methylmalonic acidemia (HP:0002912) | 1.85017946 |
| 118 | Morphological abnormality of the inner ear (HP:0011390) | 1.84006927 |
| 119 | Specific learning disability (HP:0001328) | 1.83988659 |
| 120 | Generalized tonic-clonic seizures (HP:0002069) | 1.83493315 |
| 121 | Abnormality of the foot musculature (HP:0001436) | 1.82774562 |
| 122 | Febrile seizures (HP:0002373) | 1.82651371 |
| 123 | Paraplegia (HP:0010550) | 1.82063164 |
| 124 | Stridor (HP:0010307) | 1.81881279 |
| 125 | Bowel incontinence (HP:0002607) | 1.81669963 |
| 126 | Acute encephalopathy (HP:0006846) | 1.81524856 |
| 127 | Spastic tetraparesis (HP:0001285) | 1.81245030 |
| 128 | Esotropia (HP:0000565) | 1.81235414 |
| 129 | Synostosis involving the elbow (HP:0003938) | 1.80944611 |
| 130 | Humeroradial synostosis (HP:0003041) | 1.80944611 |
| 131 | Medial flaring of the eyebrow (HP:0010747) | 1.80652686 |
| 132 | Hypomagnesemia (HP:0002917) | 1.80007141 |
| 133 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.79851220 |
| 134 | Ulnar claw (HP:0001178) | 1.79276073 |
| 135 | Focal dystonia (HP:0004373) | 1.78958482 |
| 136 | Hemiparesis (HP:0001269) | 1.78172952 |
| 137 | Optic nerve hypoplasia (HP:0000609) | 1.77649217 |
| 138 | Visual hallucinations (HP:0002367) | 1.77314573 |
| 139 | Agitation (HP:0000713) | 1.77226939 |
| 140 | Distal sensory impairment (HP:0002936) | 1.76595957 |
| 141 | Poor eye contact (HP:0000817) | 1.73741179 |
| 142 | Hepatoblastoma (HP:0002884) | 1.73648486 |
| 143 | Depression (HP:0000716) | 1.72662141 |
| 144 | Inability to walk (HP:0002540) | 1.71323219 |
| 145 | Heterochromia iridis (HP:0001100) | 1.69078675 |
| 146 | Abnormal social behavior (HP:0012433) | 1.68113634 |
| 147 | Impaired social interactions (HP:0000735) | 1.68113634 |
| 148 | Abnormality of salivation (HP:0100755) | 1.67016024 |
| 149 | Spastic paraplegia (HP:0001258) | 1.66182766 |
| 150 | Muscular hypotonia of the trunk (HP:0008936) | 1.63425621 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.49299542 |
| 2 | OXSR1 | 3.53056833 |
| 3 | CASK | 2.92541250 |
| 4 | MARK1 | 2.67219617 |
| 5 | BCR | 2.53495477 |
| 6 | MAPKAPK5 | 2.33612714 |
| 7 | CDK19 | 2.26092359 |
| 8 | PKN1 | 2.23866023 |
| 9 | EPHA4 | 2.21879207 |
| 10 | EPHB1 | 2.08619545 |
| 11 | LIMK1 | 2.00711670 |
| 12 | UHMK1 | 1.99740764 |
| 13 | PRPF4B | 1.97292690 |
| 14 | NTRK3 | 1.90037660 |
| 15 | PNCK | 1.85059781 |
| 16 | WNK4 | 1.77108424 |
| 17 | NTRK1 | 1.69329390 |
| 18 | SIK2 | 1.67001739 |
| 19 | FGFR2 | 1.63946341 |
| 20 | CAMK2B | 1.61243615 |
| 21 | CSNK1G3 | 1.60572784 |
| 22 | PAK6 | 1.59946557 |
| 23 | SGK494 | 1.58774141 |
| 24 | SGK223 | 1.58774141 |
| 25 | WNK1 | 1.51236733 |
| 26 | TNIK | 1.51031793 |
| 27 | TRIM28 | 1.47778961 |
| 28 | PBK | 1.47307362 |
| 29 | CSNK1A1L | 1.46842555 |
| 30 | MAP3K9 | 1.45914094 |
| 31 | CSNK1G2 | 1.41202348 |
| 32 | DYRK2 | 1.40372697 |
| 33 | NTRK2 | 1.38749254 |
| 34 | MAP4K2 | 1.37099430 |
| 35 | ROCK2 | 1.32789881 |
| 36 | MAPK13 | 1.32150631 |
| 37 | MAP3K4 | 1.30259149 |
| 38 | MAP2K7 | 1.29674228 |
| 39 | MET | 1.27899466 |
| 40 | TESK2 | 1.27569120 |
| 41 | MINK1 | 1.26058552 |
| 42 | CDK5 | 1.22465036 |
| 43 | PHKG2 | 1.19079573 |
| 44 | PHKG1 | 1.19079573 |
| 45 | CAMK2D | 1.18457646 |
| 46 | CAMKK1 | 1.15499312 |
| 47 | FGR | 1.14372311 |
| 48 | NEK6 | 1.14081464 |
| 49 | CSNK1G1 | 1.13152945 |
| 50 | ARAF | 1.12759939 |
| 51 | CAMK2A | 1.11199419 |
| 52 | CDK14 | 1.08300023 |
| 53 | KSR2 | 1.03471216 |
| 54 | EPHA3 | 1.00511262 |
| 55 | CAMK2G | 1.00311892 |
| 56 | CDK18 | 0.99105177 |
| 57 | CDK15 | 0.98543763 |
| 58 | PLK2 | 0.97875748 |
| 59 | EPHB2 | 0.94340300 |
| 60 | GRK5 | 0.91497042 |
| 61 | DAPK2 | 0.90187221 |
| 62 | PAK3 | 0.87556681 |
| 63 | CDK11A | 0.86792858 |
| 64 | PRKCE | 0.85153110 |
| 65 | TYRO3 | 0.84103642 |
| 66 | MARK2 | 0.84022760 |
| 67 | BMPR1B | 0.81885882 |
| 68 | ERBB3 | 0.81751687 |
| 69 | MST4 | 0.78586296 |
| 70 | SGK2 | 0.76079256 |
| 71 | CAMK1 | 0.72693552 |
| 72 | CAMKK2 | 0.71605474 |
| 73 | MUSK | 0.71507216 |
| 74 | PRKD3 | 0.69218315 |
| 75 | CLK1 | 0.68776928 |
| 76 | DYRK1B | 0.65178948 |
| 77 | PRKCG | 0.64173856 |
| 78 | ICK | 0.63764868 |
| 79 | KSR1 | 0.59063376 |
| 80 | DYRK1A | 0.58229476 |
| 81 | BCKDK | 0.55281443 |
| 82 | PRKD1 | 0.54046155 |
| 83 | PTK2B | 0.53436977 |
| 84 | PDPK1 | 0.53135922 |
| 85 | PRKCQ | 0.52632859 |
| 86 | PRKCH | 0.52448365 |
| 87 | NME1 | 0.52080617 |
| 88 | CCNB1 | 0.51848214 |
| 89 | MAP2K4 | 0.50635799 |
| 90 | TESK1 | 0.50239513 |
| 91 | FYN | 0.49867658 |
| 92 | PRKG1 | 0.49181551 |
| 93 | CAMK4 | 0.48545572 |
| 94 | ERBB4 | 0.48393096 |
| 95 | FES | 0.47994530 |
| 96 | MAP3K2 | 0.47850455 |
| 97 | DAPK1 | 0.47618255 |
| 98 | STK11 | 0.47297026 |
| 99 | GRK7 | 0.47019353 |
| 100 | PINK1 | 0.45973734 |
| 101 | BMPR2 | 0.45941600 |
| 102 | ADRBK2 | 0.45808566 |
| 103 | PRKACB | 0.44953178 |
| 104 | CSNK1A1 | 0.43840246 |
| 105 | WNK3 | 0.41029989 |
| 106 | RPS6KA3 | 0.40795312 |
| 107 | ERBB2 | 0.40237813 |
| 108 | PRKACA | 0.39209171 |
| 109 | DAPK3 | 0.38441281 |
| 110 | CSNK1E | 0.35943860 |
| 111 | CSNK1D | 0.34785137 |
| 112 | SGK1 | 0.34612054 |
| 113 | MAP3K13 | 0.34558271 |
| 114 | MAP3K12 | 0.34157718 |
| 115 | MAPK15 | 0.33099557 |
| 116 | RPS6KA4 | 0.32895087 |
| 117 | PRKCZ | 0.32417379 |
| 118 | LATS2 | 0.32413351 |
| 119 | ADRBK1 | 0.31159170 |
| 120 | LMTK2 | 0.30612047 |
| 121 | MAPK10 | 0.29927178 |
| 122 | MAP3K6 | 0.29756735 |
| 123 | SRPK1 | 0.29481254 |
| 124 | CAMK1G | 0.29361605 |
| 125 | ROCK1 | 0.29064172 |
| 126 | DYRK3 | 0.29001658 |
| 127 | PRKCA | 0.28756359 |
| 128 | SGK3 | 0.28312614 |
| 129 | RAF1 | 0.28245938 |
| 130 | STK38 | 0.27143769 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.35106182 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.37465277 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.21111038 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.07885609 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 2.41534925 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.36534391 |
| 7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.19461021 |
| 8 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.18607285 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.17927841 |
| 10 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.05274150 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.04541274 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.03805465 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.01543950 |
| 14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.93974476 |
| 15 | Morphine addiction_Homo sapiens_hsa05032 | 1.88401359 |
| 16 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.86939710 |
| 17 | Parkinsons disease_Homo sapiens_hsa05012 | 1.78613336 |
| 18 | Axon guidance_Homo sapiens_hsa04360 | 1.74344370 |
| 19 | Circadian entrainment_Homo sapiens_hsa04713 | 1.73857197 |
| 20 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.72350449 |
| 21 | Alzheimers disease_Homo sapiens_hsa05010 | 1.65078083 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.52913825 |
| 23 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.47339690 |
| 24 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.46566492 |
| 25 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.44630864 |
| 26 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.38381078 |
| 27 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.33673686 |
| 28 | Olfactory transduction_Homo sapiens_hsa04740 | 1.33523276 |
| 29 | Salivary secretion_Homo sapiens_hsa04970 | 1.32545779 |
| 30 | Taste transduction_Homo sapiens_hsa04742 | 1.30268522 |
| 31 | Cocaine addiction_Homo sapiens_hsa05030 | 1.27984526 |
| 32 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.27962698 |
| 33 | Long-term potentiation_Homo sapiens_hsa04720 | 1.27235532 |
| 34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.24341940 |
| 35 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.20201203 |
| 36 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.19329909 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.16261573 |
| 38 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.12941386 |
| 39 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.11867305 |
| 40 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.11520159 |
| 41 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.06873281 |
| 42 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.03481795 |
| 43 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.02440616 |
| 44 | Huntingtons disease_Homo sapiens_hsa05016 | 1.01773980 |
| 45 | Phototransduction_Homo sapiens_hsa04744 | 0.98677067 |
| 46 | Renin secretion_Homo sapiens_hsa04924 | 0.98157221 |
| 47 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.97230135 |
| 48 | Insulin secretion_Homo sapiens_hsa04911 | 0.96640772 |
| 49 | Gap junction_Homo sapiens_hsa04540 | 0.95729720 |
| 50 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.92115251 |
| 51 | Protein export_Homo sapiens_hsa03060 | 0.91542075 |
| 52 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.90015168 |
| 53 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.86638289 |
| 54 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.84537472 |
| 55 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.82658823 |
| 56 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.79915289 |
| 57 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.79807403 |
| 58 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79140917 |
| 59 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.76216008 |
| 60 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.76030996 |
| 61 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.75869203 |
| 62 | Histidine metabolism_Homo sapiens_hsa00340 | 0.74470210 |
| 63 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.74157200 |
| 64 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.74047454 |
| 65 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.73842275 |
| 66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.73822896 |
| 67 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.73333559 |
| 68 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.72881336 |
| 69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69945464 |
| 70 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.69589610 |
| 71 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.65931137 |
| 72 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.65313679 |
| 73 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64621678 |
| 74 | Phagosome_Homo sapiens_hsa04145 | 0.62200343 |
| 75 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61124297 |
| 76 | Tight junction_Homo sapiens_hsa04530 | 0.60723192 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.60615125 |
| 78 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.60501222 |
| 79 | Melanogenesis_Homo sapiens_hsa04916 | 0.60210152 |
| 80 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.59955513 |
| 81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59876380 |
| 82 | Circadian rhythm_Homo sapiens_hsa04710 | 0.58734914 |
| 83 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.58682519 |
| 84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57980882 |
| 85 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.56569272 |
| 86 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.54905232 |
| 87 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.54311362 |
| 88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.52874774 |
| 89 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.52496186 |
| 90 | Bile secretion_Homo sapiens_hsa04976 | 0.52441088 |
| 91 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52094107 |
| 92 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.51770809 |
| 93 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.49871862 |
| 94 | Mineral absorption_Homo sapiens_hsa04978 | 0.49222554 |
| 95 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.48814546 |
| 96 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.47870809 |
| 97 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.47006163 |
| 98 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.46420825 |
| 99 | Alcoholism_Homo sapiens_hsa05034 | 0.46325705 |
| 100 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.46113431 |
| 101 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.45816271 |
| 102 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.44469213 |
| 103 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.42742793 |
| 104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41477383 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41343964 |
| 106 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.41177481 |
| 107 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38554813 |
| 108 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.38224955 |
| 109 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.37734152 |
| 110 | Glioma_Homo sapiens_hsa05214 | 0.37105429 |
| 111 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.37018733 |
| 112 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.35768071 |
| 113 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.35012816 |
| 114 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33630087 |
| 115 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.33432299 |
| 116 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.33064349 |
| 117 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.32792649 |
| 118 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.32432576 |
| 119 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.30112942 |
| 120 | Prion diseases_Homo sapiens_hsa05020 | 0.29515211 |
| 121 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.28471651 |
| 122 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.27678152 |

